Literature DB >> 21804158

Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification.

W D Travis, E Brambilla, P Van Schil, G V Scagliotti, R M Huber, J-P Sculier, J Vansteenkiste, A G Nicholson.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21804158     DOI： 10.1183/09031936.00026711

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  16 in total

1.  Histologic Lung Cancer Incidence Rates and Trends Vary by Race/Ethnicity and Residential County.

Authors:  Keisha A Houston; Khadijah A Mitchell; Jessica King; Arica White; Bríd M Ryan
Journal:  J Thorac Oncol       Date:  2018-01-31       Impact factor: 15.609

Review 2.  Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.

Authors:  Swaroop Revannasiddaiah; Priyanka Thakur; Bhaskar Bhardwaj; Sridhar Papaiah Susheela; Irappa Madabhavi
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

3.  Computer-Aided Diagnosis of Ground-Glass Opacity Nodules Using Open-Source Software for Quantifying Tumor Heterogeneity.

Authors:  Ming Li; Vivek Narayan; Ritu R Gill; Jyothi P Jagannathan; Maria F Barile; Feng Gao; Raphael Bueno; Jagadeesan Jayender
Journal:  AJR Am J Roentgenol       Date:  2017-10-18       Impact factor: 3.959

4.  The role of molecular pathology in non-small-cell lung carcinoma-now and in the future.

Authors:  G D A Brandao; E F Brega; A Spatz
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

5.  Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.

Authors:  Keisha A Houston; S Jane Henley; Jun Li; Mary C White; Thomas B Richards
Journal:  Lung Cancer       Date:  2014-08-12       Impact factor: 5.705

6.  An Immunohistochemical Study of Anaplastic Lymphoma Kinase and Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Carcinoma.

Authors:  Sonal Verma; Madhu Kumar; Malti Kumari; Raj Mehrotra; R A S Kushwaha; Madhumati Goel; Ashutosh Kumar; Surya Kant
Journal:  J Clin Diagn Res       Date:  2017-07-01

7.  3D deep learning based classification of pulmonary ground glass opacity nodules with automatic segmentation.

Authors:  Duo Wang; Tao Zhang; Ming Li; Raphael Bueno; Jagadeesan Jayender
Journal:  Comput Med Imaging Graph       Date:  2020-12-11       Impact factor: 4.790

Review 8.  Surgical treatment of early-stage non-small-cell lung cancer.

Authors:  Paul E Van Schil; Bram Balduyck; Michèle De Waele; Jeroen M Hendriks; Marjan Hertoghs; Patrick Lauwers
Journal:  EJC Suppl       Date:  2013-09

9.  Expression of EGFR and molecules downstream to PI3K/Akt, Raf-1-MEK-1-MAP (Erk1/2), and JAK (STAT3) pathways in invasive lung adenocarcinomas resected at a single institution.

Authors:  Alba Fabiola Torres; Cleto Nogueira; Juliana Magalhaes; Igor Santos Costa; Alessa Aragao; Antero Gomes Neto; Filadelfia Martins; Fabio Tavora
Journal:  Anal Cell Pathol (Amst)       Date:  2014-12-18       Impact factor: 2.916

10.  CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.

Authors:  Erna-Elise Paulsen; Thomas Kilvaer; Mehrdad Rakaee Khanehkenari; Ramona Johansen Maurseth; Samer Al-Saad; Sigurd M Hald; Khalid Al-Shibli; Sigve Andersen; Elin Richardsen; Lill-Tove Busund; Roy Bremnes; Tom Donnem
Journal:  Neoplasia       Date:  2015-11       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.